Ratnakar Securities Pvt. Ltd.

MEDPLUS HEALTH SERVICES LTD.

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE797.2521.8 (+2.81 %)

PREV CLOSE ( ) 775.45

OPEN PRICE ( ) 781.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 18202

TODAY'S LOW / HIGH ( )779.65 803.10

52 WK LOW / HIGH ( )597.95 876.75

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-11 2006

Management Info

Gangadi Madhukar Reddy - Chairman Gangadi Madhukar Reddy - Managing Director

Registered Office

Address H. No: 11-6-56, Survey No: 257 & 258/1,Opp: I D P L Railway Siding Road,Moosapet, Kukatpally,
Hyderabad,
Telangana-500037

Phone 040-67246724

Email medplus@medplusindia.com

Website www.medplusindia.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

03Jan Medplus Health Services informs about
Medplus Health Services has informed that the exchange has received the..

01Jan Medplus Health Services informs about
Medplus Health Services has informed that the exchange has received the..

28Dec Medplus Health Services informs about
Medplus Health Services has informed that it enclosed disclosure under R..

28Dec Medplus Health Services informs about
Medplus Health Services has informed that the exchange has received the..

18Dec Allotment of Equity shares under ESOP
Inter alia, approved the following: 1. Appointment of Mr. T Muralidhara..

Financials

in Millions

	QTR Sep 24	ANNUAL 24
Net Profit	77.4700000000001	95.8099999999992
Gross Profit	96.4100000000001	70.4099999999992
Operating Profit	191.95	396.129999999999
Net Sales	1562.26	4670.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 13417.20 (0.96%)	M.Cap ( in Cr)17214.12
Procter&Gamble Healt (BSE) 5424.60 (2.04%)	M.Cap ( in Cr)9004.50
Ajanta Pharma (BSE) 2879.50 (2.30%)	M.Cap ( in Cr)35968.44
Alivus Life Sciences (BSE) 1062.45 (4.08%)	M.Cap ( in Cr)13018.50
Eris Lifesciences (BSE) 1298.75 (1.59%)	M.Cap ( in Cr)17679.79

Shareholding Pattern

	PROMOTERS	40.39%
	FI/BANKS/INSURANCE	3.03%
	MUTUAL FUNDS/UTI	18.08%
	NON-INSTITUTION	16.92%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Pharma...	3.32
Nippon India Focuse...	2.13
Bandhan Innovation ...	1.66
ICICI Pru Pharma He...	1.56
JM Aggressive Hybri...	1.53
Invesco India Large...	1.43

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

MEDPLUS HEALTH SERVICES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES